ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson.

January 12, 2007

Perifosine Increases PFS In Phase II Study

December 30, 2011

Additional DCE Contract Concepts

November 16, 1984

Women 80 And Older Benefit From Mammography

May 30, 2008

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981